Protagenic Therapeutics, Inc.\new (PTIX) Shareholders’ equity 2014–2024
Protagenic Therapeutics, Inc.\new (PTIX) shareholders’ equity at each fiscal year-end, per SEC filings.
-$3.3MFY2024 · since FY2014: -$121,353 → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$3.3M | -190.5% |
| FY2023 | $3.7M | -47.0% |
| FY2022 | $6.9M | -30.4% |
| FY2021 | $9.9M | +964.7% |
| FY2020 | -$1.1M | — |
| FY2016 | $2.5M | +471.3% |
| FY2015 | -$667,216 | -449.8% |
| FY2014 | -$121,353 | — |
Source: SEC XBRL filings · For reference only · Not investment advice